Alligator Bioscience AB (7AL0)
FSX
0.000100
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
0.0001000.000100
52 wk Range
0.0000430.4591
Financial Statements - 7AL0 - Alligator Bioscience AB
Revenue
514.00K▼ 90.5%
Net Income
-51.35M▼ 134.3%Net Margin -9990.3%
EBITDA
-115.43M▼ 872.9%
Free Cash Flow
-157.44M▼ 691.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 514K | 5.41M |
| Cost of Goods | - | - |
| Gross Profit | - | - |
 Operating Expense | - | - |
| Operating Income | -121.66M | -17.77M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | -51.35M | -21.91M |
| Income Tax | 0 | 0 |
| Net Income | -51.35M | -21.91M |
| EPS Basic | -1.87 | -13.155746 |
| EPS Diluted | -1.87 | -13.155746 |
| Basic Shares Outstanding | 27.52M | 1.67M |
| Diluted Shares Outstanding | 27.52M | 1.67M |
| Ebit | -7.08M | -20.06M |
| Ebitda | -115.43M | -11.86M |
| Net Income Continuous Operations | -105.82M | -21.46M |
| Minority Interests | - | - |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
